Table 2. A. Body weight during the treatment.
A | BW (g) | ||||||||
Treatment | Day 1 | Day 12 | Day 19 | Day 26 | Day 33 | Day 40 | Day 47 | Day 54 | Day 61 |
Lean Veh | 35.8±0.3* | 35.2±0.4* | 35.5±0.4* | 36.1±0.4* | 36.0±0.4* | 36.0±0.5* | 35.5±0.4* | 37.4±0.3* | 36.3±0.4* |
DIO Veh | 46.9±1.0 | 46.8±1.0 | 46.6±1.6 | 48.0±1.1 | 47.6±1.1 | 49.9±1.1 | 49.9±0.9 | 52.0±0.8 | 51.2±0.9 |
CB1 ASO 25mg/kg/wk | 47.3±0.9 | 47.5±0.9 | 47.6±0.9 | 47.1±1.0 | 46.5±1.0 | 46.6±0.8* | 45.9±1.0* | 47.3±0.9* | 46.1±1.0* |
CB1 ASO 12.5mg/kg/wk | 47.9±1.2 | 47.9±1.3 | 48.0±1.3 | 48.2±1.4 | 48.0±1.5 | 48.2±1.7 | 48.3±1.6 | 50.4±1.5 | 49.4±1.4 |
CB1 ASO 6.25mg/kg/wk | 47.6±1.1 | 47.4±1.3 | 48.6±1.1 | 48.6±1.1 | 48.9±1.2 | 49.2±1.2 | 49.2±1.1 | 50.9±1.2 | 49.1±1.3 |
Control ASO 25mg/kg/wk | 47.3±1.0 | 47.3±1.0 | 47.8±1.0 | 48.4±1.1 | 48.8±1.2 | 49.3±1.2 | 49.9±1.2 | 51.9±1.2 | 50.5±1.3 |
B | BW (% of starting) | ||||||||
Treatment | Day 1 | Day 12 | Day 19 | Day 26 | Day 33 | Day 40 | Day 47 | Day 54 | Day 61 |
DIO Veh | 100±2.2 | 99.9±2.0 | 99.4±3.5 | 102.4±2.4 | 101.4±2.4 | 106.5±2.2 | 106.5±1.8 | 111.0±1.8 | 109.2±1.9 |
CB1 ASO 25mg/kg/wk | 100±1.8 | 100.4±1.9 | 100.7±1.9 | 99.5±2.1 * | 98.3±2.0* | 98.5±1.7* | 97.0±2.1 * | 100.1±2.0* | 97.6±2.0* |
CB1 ASO 12.5mg/kg/wk | 100±2.5 | 100±2.7 | 100.1±2.7 | 100.6±2.9 | 100.0±3.1 | 100.5±3.5 | 100.7±3.4 | 105.0±±3.2 | 102.9±2.9 |
CB1 ASO 6.25mg/kg/wk | 100±2.4 | 99.5±2.8 | 100.2±2.2 | 102.1±2.4 | 102.6±2.5 | 103.4±2.4 | 103.3±2.4 | 106.9±2.4 | 103.3±2.8 |
Control ASO 25mg/kg/wk | 100±2.0 | 100±2.1 | 101.0±2.1 | 102.3±2.3 | 103.2±2.5 | 104.3±2.5 | 105.4±2.6 | 109.8±2.5 | 106.8±2.7 |
B. Body weight change (% of the beginning body weight) during the treatment. One way ANOVA Dunnett’s multiple test compared to DIO Veh, *p<0.05.